| Edwin Urbi A Medical Limited Liabilty Company | |
|
5920 Coliseum Blvd Alexandria LA 71303-3714 | |
| (318) 443-9339 | |
| (318) 443-9116 |
| Full Name | Edwin Urbi A Medical Limited Liabilty Company |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 5920 Coliseum Blvd, Alexandria, Louisiana |
| Authorized Official Name and Position | Tiffany A. Stephens (CREDENTIALING/DELEGATE) |
| Authorized Official Contact | 3184439339 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Edwin Urbi A Medical Limited Liabilty Company 6221 Grand Oak Dr Alexandria LA 71301-2334 Ph: () - | Edwin Urbi A Medical Limited Liabilty Company 5920 Coliseum Blvd Alexandria LA 71303-3714 Ph: (318) 443-9339 |
| NPI Number | 1376175471 |
|---|---|
| Provider Enumeration Date | 02/06/2020 |
| Last Update Date | 02/06/2020 |
| Certification Date | 02/06/2020 |
| Medicare PECOS PAC ID | 3678991809 |
|---|---|
| Medicare Enrollment ID | O20200921000036 |
News Archive
Four unsolved mysteries around schizophrenia have long plagued the medical community, but a new hypothesis identifying a common link between them and an almost forgotten epidemic of a disease called pellagra could have profound implications for our understanding of psychosis in poorer nations.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
It's estimated that as many as 1,000,000 Americans suffer from inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which cause mild to severe symptoms that at best can be managed and at worst can lead to life-threatening complications.
Two of the nation's largest healthcare information networks, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Surescripts®, The Nation's E-Prescription Network™, today announced an agreement to pioneer the formation of an integrated service to make laboratory and prescription information broadly and easily accessible to physicians.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376175471 | NPI | - | NPPES |
| 1539368 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Primary |
| Provider Name | Edwin S Urbi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1649264755 PECOS PAC ID: 7911956263 Enrollment ID: I20050113000827 |
News Archive
Four unsolved mysteries around schizophrenia have long plagued the medical community, but a new hypothesis identifying a common link between them and an almost forgotten epidemic of a disease called pellagra could have profound implications for our understanding of psychosis in poorer nations.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
It's estimated that as many as 1,000,000 Americans suffer from inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which cause mild to severe symptoms that at best can be managed and at worst can lead to life-threatening complications.
Two of the nation's largest healthcare information networks, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Surescripts®, The Nation's E-Prescription Network™, today announced an agreement to pioneer the formation of an integrated service to make laboratory and prescription information broadly and easily accessible to physicians.
› Verified 8 days ago
News Archive
Four unsolved mysteries around schizophrenia have long plagued the medical community, but a new hypothesis identifying a common link between them and an almost forgotten epidemic of a disease called pellagra could have profound implications for our understanding of psychosis in poorer nations.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
It's estimated that as many as 1,000,000 Americans suffer from inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which cause mild to severe symptoms that at best can be managed and at worst can lead to life-threatening complications.
Two of the nation's largest healthcare information networks, Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Surescripts®, The Nation's E-Prescription Network™, today announced an agreement to pioneer the formation of an integrated service to make laboratory and prescription information broadly and easily accessible to physicians.
› Verified 8 days ago
Bayou Rapides Rehab, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3620 Bayou Rapides Rd, Alexandria, LA 71303 Phone: 318-561-2010 Fax: 318-561-0098 | |
Family Counseling Agency, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1404 Murray St, Alexandria, LA 71301 Phone: 318-448-0284 Fax: 318-448-0280 | |
Merakey Pennsylvania Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 Pecan Park Ave, Suite A And B, Alexandria, LA 71303 Phone: 215-836-3131 Fax: 215-273-5975 | |
Caring Choices Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5411 Coliseum Blvd, Alexandria, LA 71303 Phone: 318-484-6850 Fax: 318-484-6844 | |
Freedom Therapy Center, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1102 Texas Ave, Alexandria, LA 71301 Phone: 318-613-0147 | |
Louisiana Counseling Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5920 Coliseum Blvd, Alexandria, LA 71303 Phone: 318-332-5090 Fax: 318-443-9116 | |
Christus St. Frances Cabrini Palliative Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3330 Masonic Dr, Suite 105, Alexandria, LA 71301 Phone: 318-449-2480 Fax: 318-448-6555 |